You are using an older browser version. Please use a supported version for the best MSN experience.

FACTBOX-Vaccines delivered under COVAX sharing scheme for poorer countries

Reuters 1/14/2022

(Updates Haiti, Mauritius, Philippines) Jan 14 (Reuters) - The COVAX facility, backed by the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), has delivered more than 987 million COVID-19 vaccine doses to 144 countries, GAVI data shows. In December COVAX set a target of achieving 70% COVID-19 immunization coverage by mid-2022. The following tables list countries that have received vaccines under the scheme, sorted alphabetically: AFRICA & MIDDLE EAST COUNTRY LATEST DELIVERY DATE VACCINE TYPE POPULATION TOTAL DELIVERY DELIVERED Algeria 3.6 million December 24 J&J 44 million 6.0 million Angola 801,000 December 25 Pfizer/BioNTech 33 million 14.8 million Benin 336,000 November 4 J&J 12 million 1.1 million Botswana 300,000 October 1 AstraZeneca/Oxford 2.5 million 560,460 Burkina Faso 504,000 December 22 J&J 21 million 1.1 million Cameroon 336,000 November 5 J&J 27 million 1.0 million Cape Verde 200,000 December 7 Pfizer/BioNTech 556,000 324,000 Central 168,300 November 19 J&J 4.8 million 806,700 African Republic Chad 117,000 October 5 Pfizer/BioNTech 16 million 217,620 Comoros 12,000 April 12 AstraZeneca/Oxford 870,000 12,000 Islands Congo 168,000 November 15 J&J 5.5 million 470,400 Democratic 349,830 October 21 Pfizer/BioNTech 90 million 2.6 million Republic of Congo Djibouti 151,200 July 17 J&J 988,000 175,200 Egypt 347,460 December 30 AstraZeneca/Oxford 102 million 18.0 million Eswatini 100,620 October 6 Pfizer/BioNTech 1.1 million 429,420 Ethiopia 7.2 million January 6 J&J 115 million 12.7 million Gabon 101,790 November 1 Pfizer/BioNTech 2.2 million 370,410 Gambia 38,400 August 22 AstraZeneca/Oxford 2.4 million 376,800 Ghana 1.7 million December 24 Pfizer/BioNTech 31 million 16.3 million Guinea 168,000 November 14 J&J 13 million 1.7 million Guinea-Bissau 28,800 August 18 AstraZeneca/Oxford 2.0 million 360,000 Iran 1.1 million December 9 AstraZeneca/Oxford 84 million 5.0 million Iraq 500,000 August 14 Pfizer/BioNTech 40 million 836,000 Ivory Coast 816,660 January 3 Pfizer/BioNTech 26 million 8.6 million Jordan 146,400 June 3 AstraZeneca/Oxford 10 million 436,800 Kenya 1.2 million December 10 J&J 54 million 16.2 million Lebanon 613,340 December 22 N/A 6.8 million 982,940 Lesotho 169,070 November 19 J&J 2.1 million 644,090 Liberia 168,000 November 27 J&J 5.1 million 830,400 Libya 1.2 million December 20 Pfizer/BioNTech 6.9 million 1.9 million Madagascar 409,500 January 4 N/A 28 million 1.7 million Malawi 360,000 October 23 AstraZeneca/Oxford 19 million 1.8 million Mali 50,400 January 7 AstraZeneca/Oxford 20 million 1.7 million Mauritania 336,000 December 6 J&J 4.6 million 1.4 million Mauritius 203,580 January 12 Pfizer/BioNTech 1.3 million 387,270 Morocco 850,000 October 30 Pfizer/BioNTech 37 million 1.2 million Mozambique 1.2 million January 7 N/A 31 million 7.2 million Namibia 124,000 October 22 Pfizer/BioNTech 2.5 million 291,200 Niger 398,970 January 8 Pfizer/BioNTech 24 million 1.2 million Nigeria 3.6 million October 16 Pfizer/BioNTech 206 million 12.0 million Palestinian 453,600 December 29 Moderna 4.7 million 1.1 million Territories Rwanda 314,730 December 25 Pfizer/BioNTech 13 million 2.8 million Sao Tome and 24,000 March 3 AstraZeneca/Oxford 219,000 24,000 Principe Senegal 265,590 November 15 Pfizer/BioNTech 17 million 2.9 million Seychelles 39,780 December 17 Pfizer/BioNTech 98,460 74,880 Sierra Leone 168,000 November 23 J&J 8.0 million 785,310 Somalia 336,500 November 7 J&J 16 million 1.2 million South Africa 5.6 million July 31 Pfizer/BioNTech 59 million 5.6 million South Sudan 336,000 December 21 J&J 11 million 908,450 Sudan 499,590 October 7 Pfizer/BioNTech 44 million 2.1 million Syria 144,000 November 16 AstraZeneca/Oxford 17 million 1.7 million Tanzania 115,200 December 3 J&J 60 million 3.1 million Togo 633,600 November 25 J&J 8.3 million 3.0 million Tunisia 168,000 December 17 J&J 12 million 4.1 million Uganda 2.0 million December 6 J&J 46 million 11.3 million Yemen 1.2 million December 20 N/A 30 million 2.1 million Zambia 336,000 December 22 N/A 18 million 3.1 million Zimbabwe 943,200 October 1 Sinopharm 15 million 943,200 EUROPE COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL DELIVERY DATE DELIVERED Albania 40,800 June 2 AstraZeneca/Oxford 2.8 million 120,000 Armenia 187,200 September 5 AstraZeneca/Oxford 3.0 million 261,200 Azerbaijan 84,000 April 4 AstraZeneca/Oxford 10 million 84,000 Bosnia 32,760 May 10 Pfizer/BioNTech 3.3 million 82,560 Georgia 43,200 March 13 AstraZeneca/Oxford 3.7 million 43,200 Kosovo 503,100 September 6 Pfizer/BioNTech 1.8 million 701,220 Moldova 301,000 August 1 J&J 2.6 million 644,000 Montenegro 24,000 March 28 AstraZeneca/Oxford 622,000 24,000 North 38,400 May 14 AstraZeneca/Oxford 2.1 million 62,400 Macedonia Serbia 115,200 August 25 AstraZeneca/Oxford 6.9 million 292,800 Ukraine 2.9 million November 7 Moderna 44 million 7.4 million ASIA & PACIFIC COUNTRY LATEST DELIVERY DELIVERY VACCINE TYPE POPULATION TOTAL DATE DELIVERED Afghanistan 2.0 million December 23 J&J 39 million 6.2 million Bangladesh 3.0 million December 27 N/A 165 million 34.2 million Brunei 24,000 April 2 AstraZeneca/Oxford 437,000 24,000 Cambodia 300,000 December 19 AstraZeneca/Oxford 17 million 2.9 million East Timor 100,620 October 16 Pfizer/BioNTech 1.3 million 393,420 Fiji 50,400 November 18 Moderna 896,000 302,480 Indonesia 3.0 million December 28 Pfizer/BioNTech 274 million 46.2 million Kiribati 56,000 August 21 AstraZeneca/Oxford 119,000 104,000 Kyrgyzstan 49,140 December 13 Pfizer/BioNTech 6.6 million 650,540 Laos 799,110 January 2 Pfizer/BioNTech 7.3 million 5.0 million Malaysia 559,200 September AstraZeneca/Oxford 32 million 1.4 million 17 Maldives 100,620 December 21 Pfizer/BioNTech 541,000 453,940 Mongolia 899,730 October 6 Pfizer/BioNTech 3.3 million 1.3 million Nauru 7,200 April 2 AstraZeneca/Oxford 10,830 7,200 Nepal 664,560 December 24 Pfizer/BioNTech 29 million 12.1 million Pakistan 1.5 million December 28 Moderna 221 million 39.1 million Papua New 302,400 August 6 J&J 8.9 million 580,400 Guinea Philippines 168,000 January 11 Moderna 110 million 48.4 million Samoa 112,000 August 23 AstraZeneca/Oxford 198,410 136,000 Solomon 100,620 November 16 Pfizer/BioNTech 687,000 209,420 Islands Sri Lanka 820,000 December 20 Pfizer/BioNTech 22 million 5.0 million Tajikistan 299,520 December 18 Pfizer/BioNTech 9.5 million 3.5 million Tonga 36,800 August 25 AstraZeneca/Oxford 106,000 60,800 Tuvalu 4,800 April 8 AstraZeneca/Oxford 11,800 4,800 Uzbekistan 500,400 January 10 Moderna 34 million 9.6 million Vanuatu 24,000 May 19 AstraZeneca/Oxford 307,000 24,000 Vietnam 4.4 million December 11 Pfizer/BioNTech 97 million 32.4 million AMERICAS COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL DELIVERY DATE DELIVERED Antigua and 19,200 November 22 N/A 98,000 60,000 Barbuda Argentina 960,400 October 12 AstraZeneca/Oxford 45 million 3.9 million Bahamas 57,330 October 18 Pfizer/BioNTech 393,000 124,530 Barbados 14,040 December 16 Pfizer/BioNTech 287,000 114,840 Belize 58,500 October 26 Pfizer/BioNTech 398,000 159,300 Bermuda 9,600 April 6 AstraZeneca/Oxford 64,000 9,600 Bolivia 472,800 January 1 Moderna 12 million 6.7 million Brazil 2.0 million September 20 Sinovac 213 million 11.9 million Chile 331,000 May 20 AstraZeneca/Oxford 19 million 489,400 Colombia 5.5 million January 3 Pfizer/BioNTech 51 million 16.5 million Costa Rica 86,400 September 5 AstraZeneca/Oxford 5.1 million 398,550 Dominica 63,180 December 14 Pfizer/BioNTech 72,000 103,680 Dominican 184,800 August 27 AstraZeneca/Oxford 11 million 463,200 Republic Ecuador 1.4 million December 6 Sinovac 18 million 2.3 million El Salvador 188,370 August 27 Pfizer/BioNTech 6.5 million 3.6 million Grenada 69,030 December 16 Pfizer/BioNTech 113,000 114,630 Guatemala 1.0 million December 16 Pfizer/BioNTech 17 million 4.3 million Guyana 42,120 December 6 Pfizer/BioNTech 787,000 262,740 Haiti 39,780 January 11 Pfizer/BioNTech 11 million 862,980 Honduras 250,040 October 28 Moderna 9.9 million 4.8 million Jamaica 98,280 December 8 Pfizer/BioNTech 3.0 million 1.0 million Mexico 2.2 million May 27 AstraZeneca/Oxford 129 million 3.3 million Nicaragua 502,550 December 24 AstraZeneca/Oxford 6.6 million 3.7 million Panama 74,400 September 15 AstraZeneca/Oxford 4.3 million 148,800 Paraguay 39,600 September 30 Sinopharm 7.1 million 1.2 million Peru 1.2 million November 10 Sinopharm 33 million 3.6 million Saint Kitts and 21,600 April 7 AstraZeneca/Oxford 53,000 21,600 Nevis Saint Lucia 7,200 December 28 J&J 184,000 197,430 Saint Vincent 70,200 December 14 Pfizer/BioNTech 111,000 115,800 and the Grenadines Suriname 64,800 December 14 AstraZeneca/Oxford 587,000 144,000 Trinidad and 84,000 November 27 Sinopharm 1.4 million 185,200 Tobago Uruguay 50,400 September 1 AstraZeneca/Oxford 3.5 million 148,800 Venezuela 3.1 million January 4 Sinopharm 28 million 9.0 million Sources: WHO, UNICEF, GAVI, releases from local authorities (Compiled by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou, Aleksandra Jasiurska and Elizaveta Gladun; Edited by Milla Nissi)

Video: New “no strings attached” TX-based COVID vaccine looks to combat global spread (MSNBC)